Finance

Lists
600381:SHA
Qinghai Spring Medicinl Rsrcs Tech CoLTD
CNÂ¥4,35
-0,23%
(-0,010) 1D
15 Okt., 15:00:02 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600381...
Open
CNÂ¥4,28
High
CNÂ¥4,41
Low
CNÂ¥4,22
Mkt. cap
2,50 mjd
Avg. vol.
5,68 m
Volume
5,29 m
52-wk high
CNÂ¥5,90
52-wk low
CNÂ¥2,48
EPS
-CNÂ¥0,15
Shares outstanding
588,08 m
No. of employees
134
Open
CNÂ¥4,28
High
CNÂ¥4,41
Low
CNÂ¥4,22
Mkt. cap
2,50 mjd
Avg. vol.
5,68 m
Volume
5,29 m
52-wk high
CNÂ¥5,90
52-wk low
CNÂ¥2,48
EPS
-CNÂ¥0,15
Shares outstanding
588,08 m
No. of employees
134
News stories
From web sources and news partners
About Qinghai Spring Medicinl Rsrcs Tech CoLTD
CEO-
Employees134
Founded28 Aug. 1998
Headquarters-
SectorPharmaceutical industry
Websiteverygrass.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
87,66 m
130,89 m
43,80 m
15,30 m
Cost of goods sold
62,27 m
100,52 m
27,66 m
6,96 m
Cost of revenue
62,27 m
100,52 m
27,66 m
6,96 m
Research and development expenses
2,62 m
985,12 k
2,19 m
6,64 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
25,13 m
39,40 m
29,54 m
30,13 m
Operating expense
25,19 m
51,68 m
32,55 m
38,03 m
Total operating expenses
87,46 m
152,21 m
60,21 m
45,00 m
Operating income
192,37 k
-21,31 m
-16,41 m
-29,70 m
Other non operating income
-419,89 k
211,42 k
-1,36 m
1,23 m
EBT including unusual items
-3,23 m
-28,76 m
-16,26 m
-27,56 m
EBT excluding unusual items
378,39 k
-9,03 m
-16,24 m
-29,52 m
Income tax expense
645,26 k
6,18 m
26,62 k
-7,74 m
Effective tax rate
-19,97%
-21,47%
-0,16%
28,08%
Other operating expenses
-3,06 m
4,85 m
815,80 k
1,41 m
Net income
-4,15 m
-34,49 m
-16,28 m
-19,82 m
Net profit margin
-4,73%
-26,35%
-37,16%
-129,56%
Earnings per share
-
-
-
-
Interest and investment income
305,78 k
12,16 m
1,58 m
906,14 k
Interest expense
-
-36,77 k
-42,51 k
-15,49 k
Net interest expenses
305,78 k
12,12 m
1,54 m
890,64 k
Depreciation and amortization charges
-
-
-
-
EBITDA
5,21 m
-17,17 m
-12,27 m
-25,88 m
Gain or loss from assets sale
228,45 k
-15,38 k
-
23,72 k
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme